{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for oxandrolone in Any Name (approximate match)
Status:
US Approved Rx
(2015)
Source:
ANDA204851
(2015)
Source URL:
First approved in 1938
Class (Stereo):
CHEMICAL (ABSOLUTE)
Conditions:
Methyltestosterone is an anabolic steroid hormone used to treat men with a testosterone deficiency. It is also used in women to treat breast cancer, breast pain, swelling due to pregnancy, and with the addition of estrogen it can treat symptoms of menopause. The effects of testosterone in humans and other vertebrates occur by way of two main mechanisms: by activation of the androgen receptor (directly or as DHT), and by conversion to estradiol and activation of certain estrogen receptors. Free testosterone (T) is transported into the cytoplasm of target tissue cells, where it can bind to the androgen receptor, or can be reduced to 5α-dihydrotestosterone (DHT) by the cytoplasmic enzyme 5α-reductase. DHT binds to the same androgen receptor even more strongly than T, so that its androgenic potency is about 2.5 times that of T. The T-receptor or DHT-receptor complex undergoes a structural change that allows it to move into the cell nucleus and bind directly to specific nucleotide sequences of the chromosomal DNA. The areas of binding are called hormone response elements (HREs), and influence transcriptional activity of certain genes, producing the androgen effects. Methyltestosterone is marketed under the brand names Android, Androral, Metandren, Oraviron, Testred, Virilon.
Status:
Other
Class (Stereo):
CHEMICAL (ABSOLUTE)
Targets:
Conditions:
Methyl-1-testosterone(M1T)(17alpha-hydroxy-17-methyl-
5-androst-1-en-3-one) is a new designer steroid that is most likely produced to circumvent
the legal restrictions. It is advertised to be highly
anabolic and moderately androgenic and not convertible
to estrogens. However, in scientific literature, it was reported
to show anabolic properties of 25% and androgenic
properties of 50% compared with testosterone propionate
after im injection in castrated rats. In February
2006, Health Canada (Federal Department) warned consumers
not to use M1T-containing products because of
potentially serious health risks such as liver disorders and
hardening of the arteries. Since 2006, M1T is explicitly listed on the
World Anti-Doping Agency list of prohibited substances,
and therefore, its use by athletes is prohibited.